European Industry Backs Biosimilars ‘Scorecards’
Ratings Provide Analyses Of Biosimilar Policies In 12 Countries
• By Akriti Seth
‘Scorecards’ prove that biosimilars are a win for patients, policymakers and healthcare systems across Europe • Source: Shutterstock 
